Development of brain plaque implicated in Alzheimer's disease seems to be reduced with a certain antidepressant, reported Scientists on Wednesday, this time by studying young people without dementia.
The antidepressant citalopram lowered by 37 percent the amount of amyloid beta, the main ingredient in brain plaques, in a selection of 23 healthy adults aged 18-50.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
The findings were published in the journal Science Translational Medicine.
Citalopram, a common selective serotonin reuptake inhibitor (SSRI) that was approved for the US market in 1998, also stopped the growth of existing brain plaques in mice with a model of Alzheimer's disease and cut new plaque growth 78 percent.
![HRT Does Not Increase Risk of Dementia in Postmenopausal Women: New Study]( "HRT Does Not Increase Risk of Dementia in Postmenopausal Women: New Study")
HRT does not increase the risk of dementia in women, a new study claims.
Previous research has found some elderly people who have taken antidepressants also have less amyloid plaque than people who have not taken the mood-enhancing drugs.
Still researchers cautioned that they have not yet found evidence of a cause and effect.
"We are a long way from making a statement regarding the ability of SSRIs to prevent the cognitive decline associated with AD," said lead author Yvette Sheline, professor of psychiatry, radiology and neurology at the University of Pennsylvania.
The patients in this study were followed for a 24 hour period. Future research will focus again on elderly people who take antidepressants, and follow them for a two-week period.
"If we see a drop in levels of amyloid beta in their spinal fluid after two weeks, then we will know that this beneficial reduction in amyloid beta is sustainable," Sheline said.
Alzheimer's disease affects five million people in the United States, where it is the sixth leading cause of death.
The number of people with Alzheimer's is expected to grow in the coming decades as population expands and more people live to old age.
Source: AFP
HRT Does Not Increase Risk of Dementia in Postmenopausal Women: New Study
HRT does not increase the risk of dementia in women, a new study claims.
Advertisement
Previous research has found some elderly people who have taken antidepressants also have less amyloid plaque than people who have not taken the mood-enhancing drugs.
Still researchers cautioned that they have not yet found evidence of a cause and effect.
"We are a long way from making a statement regarding the ability of SSRIs to prevent the cognitive decline associated with AD," said lead author Yvette Sheline, professor of psychiatry, radiology and neurology at the University of Pennsylvania.
The patients in this study were followed for a 24 hour period. Future research will focus again on elderly people who take antidepressants, and follow them for a two-week period.
"If we see a drop in levels of amyloid beta in their spinal fluid after two weeks, then we will know that this beneficial reduction in amyloid beta is sustainable," Sheline said.
Alzheimer's disease affects five million people in the United States, where it is the sixth leading cause of death.
The number of people with Alzheimer's is expected to grow in the coming decades as population expands and more people live to old age.
Source: AFP
Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer's disease.
Advertisement
 Caring for Alzheimers disease patientsAlzheimer's disease is a complex brain disorder that triggers the most common form of dementia. The slide show will show how patients need support and care as dementia progresses. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
Cerebrospinal fluid (CSF) leaks are detected in approximately 1-3% of adults who have experienced a traumatic brain injury.
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
In Alzheimer's disease condition, the control and adjustment of ABCA7 levels in response to inflammation and the decrease in the availability of cholesterol.
Atopic dermatitis (AD) and inflammatory bowel disease (IBD) can lead to alterations in the microbiome, and disruptions in the skin and gut barrier.
